In males, there was an increasing trend in standardized DALY rates for multiple myeloma (AAPC = 4.66%, 95% CI: 4.52–4.80%), neuroblastoma and other peripheral nervous cell tumors (AAPC = 4.32%, 95% CI: 4.24–4.39%), and breast cancer (AAPC = 1.53%, 95% CI: 1.48–1.57%).
← all excerpts
Trends in the disease burden of early-onset cancers in China from 1990 to 2021: a systematic analysis of the 2021 Global Burden of Disease study.
1
—
—